Medullary, anaplastic, and metastatic cancers of the thyroid

Seminars in Oncology

Volumn 37, Issue 6, 2010, Pages 567-579

  Pitt, Susan C ^a   Moley, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; BISPHOSPHONIC ACID DERIVATIVE; BRESTATIN; CALCITONIN; CALCIUM; CARBOPLATIN; CARCINOEMBRYONIC ANTIGEN; DACARBAZINE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IMATINIB; NATURAL PRODUCT; PACLITAXEL; PARATHYROID HORMONE; PAZOPANIB; PEMETREXED; PROTEIN TYROSINE KINASE INHIBITOR; RADIOACTIVE IODINE; SORAFENIB; SUNITINIB; UNCLASSIFIED DRUG; VENDATINIB;

ANAPLASTIC CARCINOMA; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER GENE THERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; EXTERNAL BEAM RADIOTHERAPY; FAMILIAL CANCER; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; METASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE ENDOCRINE NEOPLASIA; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PARATHYROIDECTOMY; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; THYROID CANCER; THYROID GLAND; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; ULTRASOUND;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, MEDULLARY; HUMANS; MOLECULAR TARGETED THERAPY; NEOPLASM STAGING; NEOPLASTIC SYNDROMES, HEREDITARY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 78650253816     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2010.10.010     Document Type: Article

References (100)

1. American Cancer Society cancer facts and figures 2009 www.cancer.org Accessed March 1, 2010
2. L. Davies, and H. Welch Increasing incidence of thyroid cancer in the United States, 1973-2002 JAMA 295 2006 2164 2167
3. F. Gilliland, W. Hunt, D. Morris, and C. Key Prognostic factors for thyroid carcinoma A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991 Cancer 79 1997 564 573
4. S. Hundahl, I. Fleming, A. Fremgen, and H. Menck A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 Cancer 83 1998 2638 2648
5. S. Sherman Thyroid carcinoma Lancet 361 2003 501 511
6. B. Panigrahi, S. Roman, and J. Sosa Medullary thyroid cancer: are practice patterns in the United States discordant from American Thyroid Association guidelines? Ann Surg Oncol 17 2010 1490 1498
7. E. Kebebew, P. Ituarte, A. Siperstein, Q. Duh, and O. Clark Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems Cancer 88 2000 1139 1148
8. E. Fialkowski, and J. Moley Current approaches to medullary thyroid carcinoma, sporadic and familial J Surg Oncol 94 2006 737 747
9. T. Moo-Young, A. Traugott, and J. Moley Sporadic and familial medullary thyroid carcinoma: state of the art Surg Clin North Am 89 2009 1193 1204
10. Z. Liu, J. Falola, and X. Zhu Antiproliferative effects of Src inhibition on medullary thyroid cancer J Clin Endocrinol Metab 89 2004 3503 3509
11. M. Kouvaraki, S. Shapiro, and N. Perrier RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors Thyroid 15 2005 531 544
12. S. Pitt, and H. Chen The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer Surgery 144 2008 721 724
13. D. Chi, and J. Moley Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia Surg Oncol Clin North Am 7 1998 681 706
14. K. Kaserer, C. Scheuba, and N. Neuhold C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin Am J Surg Pathol 22 1998 722 728
15. K. Kaserer, C. Scheuba, and N. Neuhold Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients Am J Surg Pathol 25 2001 1245 1251
16. A. Weinhaeusel, C. Scheuba, and M. Lauss The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma Thyroid 18 2008 1269 1276
17. nd ed. 2005 Elsevier Saunders Philadelphia 129 141
18. J. Moley, and M. DeBenedetti Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection Ann Surg 229 1999 880 887
19. T. Musholt, P. Goodfellow, G. Scheumann, R. Pichlmayr, S.J. Wells, and J. Moley Differential display in primary and metastatic medullary thyroid carcinoma J Surg Res 69 1997 94 100
20. M. Brandi, R. Gagel, and A. Angeli Guidelines for diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 2001 5658 5671
21. J. Howe, J. Norton, and S.J. Wells Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up Surgery 114 1993 1070 1077
22. J. Ogilvie, and E. Kebebew Indication and timing of thyroid surgery for patients with hereditary medullary thyroid cancer syndromes J Natl Compr Cancer Network 4 2006 139 147
23. F. Quayle, R. Benveniste, M. DeBenedetti, S. Wells, and J. Moley Hereditary medullary thyroid carcinoma in patients greater than 50 years old Surgery 136 2004 1116 1121
24. M. Kouvaraki, J. Lee, and S. Shapiro Genotype-phenotype analysis in multiple endocrine neoplasia type 1 Arch Surg 137 2002 641 647
25. R. Hubner, and R. Houlston Molecular advances in medullary thyroid cancer diagnostics Clin Chim Acta 370 2006 2 8
26. R.M. Tuttle, D.W. Ball, and D. Byrd NCCN clinical practice guidelines in oncology: thyroid carcinoma J Natl Compr Cancer Netw 8 2010 512 530
27. R. Kloos, C. Eng, and D. Evans Medullary thyroid cancer: management guidelines of the American Thyroid Association Thyroid 19 2009 565 612
28. A. Machens, P. Niccoli-Sire, and J. Hoegel Early malignant progression of hereditary medullary thyroid cancer N Engl J Med 349 2003 1517 1525
29. A. Machens, and H. Dralle Prophylactic thyroidectomy in RET carriers at risk for hereditary medullary thyroid cancer Thyroid 19 2009 551 554
30. K. Ain Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches Thyroid 8 1998 715 726
31. H. Dralle Lymph node dissection and medullary thyroid carcinoma Br J Surg 89 2002 1073 1075
32. J. Moley, W. Dilley, and M. DeBenedetti Improved results of cervical reoperation for medullary thyroid carcinoma Ann Surg 225 1997 734 740
33. F. Quayle, and J. Moley Medullary thyroid carcinoma: management of lymph node metastases Curr Treat Options Oncol 6 2005 347 354
34. M. Cohen, and J. Moley Surgical treatment of medullary thyroid carcinoma J Intern Med 253 2003 616 626
35. F. Quayle, and J. Moley Medullary thyroid carcinoma: including MEN 2A and MEN 2B syndromes J Surg Oncol 89 2005 122 129
36. S. Hundahl, B. Cady, M. Cunningham U.S. and German Thyroid Cancer Study Group Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996 An American College of Surgeons Commission on Cancer Patient Care Evaluation study Cancer 89 2000 202 217
37. L. Rosato, N. Avenia, and P. Bernante Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years World J Surg 28 2004 271 276
38. W. Tung, T. Vesely, and J. Moley Laparoscopic detection of hepatic metastases in patients with residual or recurrent medullary thyroid cancer Surgery 118 1995 1024 1029
39. E. Fialkowski, M. DeBenedetti, and J. Moley Long-term outcome of reoperations for medullary thyroid carcinoma World J Surg 32 2008 754 765
40. E. Kebebew, S. Kikuchi, Q. Duh, and O. Clark Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer Arch Surg 135 2000 895 901
41. M. Catalano, R. Poli, M. Pugliese, N. Fortunati, and G. Boccuzzi Emerging molecular therapies of advanced thyroid cancer Mol Aspects Med 31 2010 215 226
42. M. Cohen, H. Hussain, and J. Moley Inhibition of medullary thyroid carcinoma cell proliferation and RET phosphorylation by tyrosine kinase inhibitors Surgery 132 2002 960 966
43. M. Higgins, A. Forastiere, and S. Marur New directions in the systemic treatment of metastatic thyroid cancer Oncology (Williston Park) 23 2009 768 775
44. E. Lam, M. Ringel, and R. Kloos Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer J Clin Oncol 28 2010 2323 2330
45. A. Machens, J. Ukkat, M. Brauckhoff, O. Gimm, and H. Dralle Advances in the management of hereditary medullary thyroid cancer J Intern Med 257 2005 50 59
46. A. Matuszczyk, S. Petersenn, and W. Voigt Chemotherapy with paclitaxel and gemcitabine in progressive medullary and thyroid carcinoma of the follicular epithelium Horm Metab Res 42 2010 61 64
47. A. Traugott, and J. Moley Medullary thyroid cancer: medical management and follow-up Curr Treat Options Oncol 6 2005 339 346 (Pubitemid 41223387)
48. S.J. Wells, J. Gosnell, and R. Gagel Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer J Clin Oncol 28 2010 767 772
49. S. Roman, R. Lin, and J. Sosa Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases Cancer 107 2006 2134 2142
50. J. Clark, T. Fridman, M. Odell, J. Brierley, P. Walfish, and J. Freeman Prognostic variables and calcitonin in medullary thyroid cancer Laryngoscope 115 2005 1445 1450 (Pubitemid 41105855)
51. S. Boostrom, C. Grant, and G. Thompson Need for a revised staging consensus in medullary thyroid carcinoma Arch Surg 144 2009 663 669
52. P. Haigh, P. Ituarte, and H. Wu Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival Cancer 91 2001 2335 2342
53. C. Are, and A. Shaha Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches Ann Surg Oncol 13 2006 453 464
54. A. Pichardo-Lowden, S. Durvesh, S. Douglas, W. Todd, M. Bruno, and D. Goldenberg Anaplastic thyroid carcinoma in a young woman: a rare case of survival Thyroid 19 2009 775 779
55. S. Chiacchio, A. Lorenzoni, G. Boni, D. Rubello, R. Elisei, and G. Mariani Anaplastic thyroid cancer: prevalence, diagnosis and treatment Minerva Endocrinol 33 2008 341 357
56. R. Neff, W. Farrar, R. Kloos, and K. Burman Anaplastic thyroid cancer Endocrinol Metab Clin North Am 37 2008 525 538
57. R. Quiros, H. Ding, P. Gattuso, R. Prinz, and X. Xu Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations Cancer 103 2005 2261 2268
58. B. Stringer, J. Rowson, and M. Parkar Detection of the H-RAS oncogene in human thyroid anaplastic carcinomas Experientia 45 1989 372 376
59. N. Lemoine, E. Mayall, and F. Wyllie Activated ras oncogenes in human thyroid cancers Cancer Res 48 1988 4459 4463
60. N. Lemoine, E. Mayall, and F. Wyllie High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis Oncogene 4 1989 159 164
61. R. Donghi, A. Longoni, S. Pilotti, P. Michieli, G. Della Porta, and M. Pierotti Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland J Clin Invest 91 1993 1753 1760
62. J. Fagin, K. Matsuo, A. Karmakar, D. Chen, S. Tang, and H. Koeffler High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas J Clin Invest 91 1993 179 184
63. K. Lam, C. Lo, K. Chan, and K. Wan Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21 Ann Surg 231 2000 329 338
64. A. Dackiw Anaplastic thyroid cancer Cancer Treat Res 153 2010 75 84
65. J. Chen, J. Tward, D. Shrieve, and Y. Hitchcock Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the Surveillance, Epidemiology, and End Results 1983-2002 Am J Clin Oncol 31 2008 460 464
66. T. Hadar, C. Mor, J. Shvero, R. Levy, and K. Segal Anaplastic carcinoma of the thyroid Eur J Surg Oncol 19 1993 511 516
67. Y. Venkatesh, N. Ordonez, P. Schultz, R. Hickey, H. Goepfert, and N. Samaan Anaplastic carcinoma of the thyroid A clinicopathologic study of 121 cases Cancer 66 1990 321 330 (Pubitemid 20205915)
68. R. Tan, Rr Finley, D. Driscoll, V. Bakamjian, W.J. Hicks, and D. Shedd Anaplastic carcinoma of the thyroid: a 24-year experience Head Neck 17 1995 41 47
69. J. Tennvall, G. Lundell, and P. Wahlberg Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery Br J Cancer 86 2002 1848 1853
70. B. McIver, I. Hay, and D. Giuffrida Anaplastic thyroid carcinoma: a 50-year experience at a single institution Surgery 130 2001 1028 1034
71. E. Kebebew, F. Greenspan, O. Clark, K. Woeber, and A. McMillan Anaplastic thyroid carcinoma Treatment outcome and prognostic factors Cancer 103 2005 1330 1335
72. E. Junor, J. Paul, and N. Reed Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy Eur J Surg Oncol 18 1992 83 88
73. T. Kobayashi, H. Asakawa, and K. Umeshita Treatment of 37 patients with anaplastic carcinoma of the thyroid Head Neck 18 1996 36 41 (Pubitemid 26002035)
74. J. Pierie, A. Muzikansky, R. Gaz, W. Faquin, and M. Ott The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma Ann Surg Oncol 9 2002 57 64
75. S. Shinohara, M. Kikuchi, and Y. Naito Successful treatment of locally advanced anaplastic thyroid carcinoma by chemotherapy and hyperfractionated radiotherapy Auris Nasus Larynx 36 2009 729 732
76. A. Swaak-Kragten, J. de Wilt, P. Schmitz, M. Bontenbal, and P. Levendag Multimodality treatment for anaplastic thyroid carcinomatreatment outcome in 75 patients Radiother Oncol 92 2009 100 104
77. T. Yau, C. Lo, R. Epstein, A. Lam, K. Wan, and B. Lang Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy Ann Surg Oncol 15 2008 2500 2505
78. K. Ain, M. Egorin, and P. DeSimone Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group Thyroid 10 2000 587 594
79. A. Bhatia, A. Rao, and K. Ang Anaplastic thyroid cancer: clinical outcomes with conformal radiotherapy Head Neck 32 2010 928 936
80. D. Heron, S. Karimpour, and P. Grigsby Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups Am J Clin Oncol 25 2002 442 446
81. N. Pennell, G. Daniels, and R. Haddad A phase II study of gefitinib in patients with advanced thyroid cancer Thyroid 18 2008 317 323
82. 18F-FDG PET in the management of patients with anaplastic thyroid carcinoma Thyroid 18 2008 713 719
83. T. Kim, K. Kim, and T. Jung Prognostic factors for Korean patients with anaplastic thyroid carcinoma Head Neck 29 2007 765 772
84. I. Sugitani, N. Kasai, Y. Fujimoto, and A. Yanagisawa Prognostic factors and therapeutic strategy for anaplastic carcinoma of the thyroid World J Surg 25 2001 617 622
85. H. Chen, T. Nicol, and R. Udelsman Clinically significant, isolated metastatic disease to the thyroid gland World J Surg 23 1999 177 180
86. C. Heffess, B. Wenig, and L. Thompson Metastatic renal cell carcinoma to the thyroid gland: a clinicopathologic study of 36 cases Cancer 95 2002 1869 1878
87. K. Lam, and C. Lo Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients Arch Pathol Lab Med 122 1998 37 41
88. J. Lin, H. Weng, and Y. Ho Clinical and pathological characteristics of secondary thyroid cancer Thyroid 8 1998 149 153
89. M. Nakhjavani, H. Gharib, J. Goellner, and J. van Heerden Metastasis to the thyroid gland A report of 43 cases Cancer 79 1997 574 578
90. H. Liang, C. Wu, K. Tam, C. Chai, S. Lin, and S. Chen Thyroid metastasis in a patient with hepatocellular carcinoma: case report and review of literature World J Surg Oncol 5 2007 144
91. T. Kim, W. Kim, G. Gong, S. Hong, and Y. Shong Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy Clin Endocrinol (Oxf) 62 2005 236 241
92. S. Cicho, R. Anielski, A. Konturek, M. Barczyski, and W. Cicho Metastases to the thyroid gland: seventeen cases operated on in a single clinical center Langenbecks Arch Surg 391 2006 581 587
93. K. Wood, L. Vini, and C. Harmer Metastases to the thyroid gland: the Royal Marsden experience Eur J Surg Oncol 30 2004 583 588
94. K. Shimaoka, J. Sokal, and J. Pickren Metastatic neoplasms in the thyroid gland Pathological and clinical findings Cancer 15 1962 557 565
95. S. Silverberg, and R. Vidone Carcinoma of the thyroid in surgical and postmortem material Analysis of 300 cases at autopsy and literature review Ann Surg 164 1966 291 299
96. O. Hull Critical analysis of two hundred twenty-one thyroid glands; study of thyroid glands obtained at necropsy in Colorado AMA Arch Pathol 59 1955 291 311
97. L. Stoll, S. Mudali, and S. Ali Merkel cell carcinoma metastatic to the thyroid gland: Aspiration findings and differential diagnosis Diagn Cytopathol 38 2010 754 757
98. E. Miralli, J. Rigaud, and M. Mathonnet Management and prognosis of metastases to the thyroid gland J Am Coll Surg 200 2005 203 207
99. G. Papi, G. Fadda, and S. Corsello Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience Clin Endocrinol (Oxf) 66 2007 565 571
100. L. Brady, E. O'Neill, and S. Farber Unusual sites of metastases Semin Oncol 4 1977 59 64